Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
AACR IO: Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy
Investigators are opening a trial to evaluate a novel type of immune cellular therapy in patients with recurrent, platinum-resistant ovarian cancer.
A mechanism for why durable weight loss is so difficult: epigenetic memory of fat cells https://www.nature.com/articles/s41586-024-08165-7
Melissa Davis, PhD, will deliver a plenary lecture during the 2024 San Antonio Breast Cancer Symposium® about the social and biological drivers that underlie racial…
Huntsman Cancer Institute at the University of Utah holds events for patients, families, caregivers, donors, and friends. We also sponsor conferences and seminars on topics…
Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally…
Published online: September 14, 2024 Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides…
Cancer Research | 84 | 22_Supplement | November 2024
The 22nd Annual Winter Lung Cancer Conference® will explore advances in neoadjuvant/adjuvant therapies. The FDA has approved Obe-cel for R/R B-ALL, and new treatments in…
Mirdametinib led to confirmed responses and meaningful pain and health-related quality of life improvements in both children and adults with neurofibromatosis type 1-associated PNs.
